![]() ![]() Turkiewicz, Leonore Unger, Raúl Veiga Cabello, Ulf Wagner, Cheng Chung Wei, Alvin F. Stack, Prashanth Sunkureddi, Hasan Tahir, Diamant Thaçi, Tsen-Fang Tsai, Anthony M. Parks, Debendra Pattanaik, Maria Rell-Bakalarska, David H. Nandagudi, Antonio Fernández-Nebro, Clark M. Kremer, Cummins Lue, José Luis Marenco de la Fuente, Helena Marzo-Ortega, Jordi Gratacós Masmitjà, Philip J. Janssen, Uta Kiltz, Alan Kivitz, Steven J. Howell, Yu-Huei Huang, Ramina Jajoo, Namieta M. Egan, Andrea Everding, Eva Galíndez, David H. Deane, Jose Del Giudice, Atul Deodhar, Rajat K. Caldron, Alain Cantagrel, Der Yuan Chen, Melvin Churchill, Christine E Codding, Peter M.G. Brooks, Gerd R Burmester, Patricia Cagnoli, Paul H. Bennett, Francisco Javier Blanco Garcia, Ricardo Blanco Alonso, Howard B. Genovese, Khalid Ahmed, Jeffrey Alper, Nichol Barkham, Ralph E. Adams, Lisa Kerr, Chin Lee, Catherine L Shuler, Mark C. ![]() Peter Nash, Bruce Kirkham, Masato Okada, Proton Rahman, B. ![]() Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial ![]()
0 Comments
Leave a Reply. |